Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)

Title: Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)
Edition: Updated
Classification: Standard guideline
Field: Comprehensive guideline
Countries and regions: China
Guidelines users: Clinical medical personnel at all levels
Evidence classification method: GRADE classification
Development unit: Chinese Medical Association
Registration time: 2024-07-22
Registration number: PREPARE-2024CN032
Purpose of the guideline: To further standardize lung cancer prevention and treatment measures in China, enhance the quality of diagnosis and treatment, improve patient prognosis, and provide evidence-based medical guidance for clinicians at all levels, the Chinese Medical Association convened experts from respiratory medicine, oncology, thoracic surgery, radiotherapy, imaging, and pathology to develop the Chinese Medical Association's Clinical Diagnosis and Treatment Guidelines for Lung Cancer (2024 edition).